Specifically, it is considered that decorin suppresses the proliferation rates and metastatic potential of multiple types of cancer cells, such as hepatocellular carcinoma, breast cancer, and non-small-cell-lung cancer [40,41,43]. This evidence concerns the gene DCN and hepatocellular carcinoma.